Showing results (621-630 of 3,032) with videos related to
Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
C5 variant is associated with decreased risk of coronary artery disease in outpatients with severe hypercholinesterasemiaDaiji Nagayama, Takeyoshi Murano, Atsuhito Saiki, et al.International Journal of Clinical Pharmacology and Therapeutics|December 28, 2016
Association between pioglitazone use and the risk of bladder cancer among subjects with diabetes mellitus: a dose-response meta-analysisZhuyue Li, Min Sun, Feng Wang, et al.International Journal of Clinical Pharmacology and Therapeutics|December 28, 2016
Bioequivalence of two formulations of pregabalin 150-mg capsules under fasting conditions in healthy male subjectsHyun A Lee, SeungHwan Lee, Sung-Vin Yim, et al.International Journal of Clinical Pharmacology and Therapeutics|March 15, 2017
Relative bioavailability of an empagliflozin 25-mg/linagliptin 5-mg fixed-dose combination tabletStephan Glund, Michaela Mattheus, Frank Runge, et al.International Journal of Clinical Pharmacology and Therapeutics|March 15, 2017
Prevalence and predictors of prescription of antibiotics in pregnant women treated by gynecologists in GermanyLouis Jacob, Matthias Kalder, Karel KostevInternational Journal of Clinical Pharmacology and Therapeutics|March 15, 2017
Intrathecal analgesia by bupivacaine is not enhanced by coadministration of morphine in patients with severe cancer-related pain: a randomized double-blind cross-over studyIngalill Reif, Anders Wincent, Carl-Olav StillerInternational Journal of Clinical Pharmacology and Therapeutics|August 10, 2019
Comparison of the gastric acid inhibition function among lansoprazole, pantoprazole, and their respective stereoisomers in healthy Chinese subjectsLei Yu, Lu-Ning Sun, Xue-Hui Zhang, et al.International Journal of Clinical Pharmacology and Therapeutics|October 30, 2018
Insulin depot absorption modeling and pharmacokinetic simulation with insulin glargine 300 U/mLKlaus Lindauer, Reinhard BeckerInternational Journal of Clinical Pharmacology and Therapeutics|October 30, 2018
Pill-count and the arithmetic of risk: Evidence that polypharmacy is a health status marker rather than a predictive surrogate for the risk of adverse drug eventsWalter E Haefeli, Andreas D MeidInternational Journal of Clinical Pharmacology and Therapeutics|November 16, 2018
Bioequivalence of fluticasone propionate and salmeterol (FS) given by the FS Spiromax® and Seretide Accuhaler® systemsDenise Wayne, Harald Iverson, Michael Gillespie, et al.Pageof 304